News & Views

Last week, members of our Porterhouse Medical team were in Vienna for EURETINA 2026, supporting pharmaceutical partners across their scientific communications programmes. Throughout the congress, our congress surveillance kept track of emerging data and competitor activity, giving our clients a clear view of the landscape to take into their post-congress planning. Planning for an upcoming …

Continue reading “Our team attended EURETINA 2026 in Vienna”

As the global incidence of Alzheimer’s disease continues to rise, predicted to reach 139 million by 2050 [1], the need for effective treatments has never been greater. This urgency is reflected in the estimated $42 billion spent on Alzheimer’s research and development over the past three decades [2], yet there remains no cure. As part …

Continue reading “World Alzheimer’s Month: Where are we in the search for a cure?”

A phase two readout lands. Weeks later, in your first regulatory meeting, you discover the new joint clinical assessment process requires comparator data you don’t have. The trial has already finished enrolling. There’s no going back to fix the design.  It’s the scenario that opens episode one of The Value Equation, our new podcast on …

Continue reading “Introducing The Value Equation: a new podcast from SCIRIS Group”

Alzheimer’s disease (AD) is a chronic and progressive neurodegenerative disease that accounts for 60%–70% of all cases of dementia globally. As the number of people with AD is projected to reach 106 million by 2050, research has increasingly focused on moving beyond symptomatic treatment to target the underlying disease aetiology itself [1]. As we enter …

Continue reading “World Alzheimer’s Month: How well do we know the disease?”

April is Parkinson’s Awareness Month, a time dedicated to highlighting the growing global impact of Parkinson’s and the urgent need for greater awareness, earlier diagnosis and improved support for those living with the condition [1]. Parkinson’s is one of the fastest growing neurological disorders worldwide, with prevalence increasing rapidly owing to ageing populations and improved …

Continue reading “From neurons to needs: Parkinson’s Awareness Month”

Bowel Cancer Awareness Month takes place every April to increase public understanding of the disease and encourage earlier recognition of symptoms. Bowel cancer, also referred to as colorectal cancer, is the fourth most common cancer and the second leading cause of cancer mortality in the UK [1, 2]. Evidence highlights increasing incidence of early-onset (before the …

Continue reading “From awareness to action: The future of bowel cancer care”

  Porterhouse Medical is thrilled to welcome Nicole Day as a Senior Medical Writer to our US-based agency. Nicole holds a BS in Molecular Biology and a PhD in Neuroscience from the University of Alabama at Birmingham. She also brings five years of medical writing expertise to her new role and holds the ‘Medical Writer …

Continue reading “Porterhouse Medical US bolsters its publications expertise”

  March marks the European Colorectal Cancer Awareness Month [1]. Globally, colorectal cancer (CRC) represents a major public health challenge. It is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide, with more than 1.9 million new cases and nearly 1 million deaths each year [2]. In the United …

Continue reading “Colorectal cancer in younger adults: A rising global concern”

  Porterhouse is delighted to welcome Laurel Ellis to the team as our newest Account Manager. Laurel joins our Global Client Services team based in our London office. She brings over two and a half years of experience in medical communications to her new role, having worked across a diverse range of therapy areas including …

Continue reading “Porterhouse welcomes an experienced Account Manager to the team”

  Over 90% of newly diagnosed cancers are solid tumours, which includes those with the highest mortality rates such as breast, lung, colorectal and prostate cancer [1,2]. Surgical resection and chemotherapy, once the backbone of solid tumour management, are increasingly limited by poor target specificity, chemotherapy resistance and tumour recurrence [3,4]. These traditional treatment strategies …

Continue reading “Precision medicine: Recent advances in targeted therapies for solid tumour treatment”

  We’re delighted to welcome Sara Gibson to Porterhouse Medical US as an Associate Medical Director within our global Scientific Services team. Sara joins us with a strong scientific background, holding a PhD in Immunology from the University of Alabama at Birmingham, and is an International Society for Medical Publication Professionals (ISMPP) Certified Medical Publications …

Continue reading “Porterhouse adds to its medical publications expertise: Welcome Sara”

  Porterhouse Medical is thrilled to welcome the latest member of our global scientific services team, Jade Roberts. Jade has joined our growing agency as an Associate Medical Writer. She brings strong scientific and educational expertise to her new role, as she holds a BSc (Hons) from the University of Reading and an MRes from …

Continue reading “Porterhouse Medical boosts its oncology expertise”